In our study, the content of APOL1 in the bladder cancer, cystitis and upper urinary tract cancer samples was higher than that in the healthy control samples, suggesting that the protein is highly expressed in the urine of patients with urinary diseases. Here, APOL1 is linked to urinary bladder carcinoma.